Matinas BioPharma Holdings (MTNB) Dividends payables (2017 - 2019)

Matinas BioPharma Holdings (MTNB) has 3 years of Dividends payables data on file, last reported at $600000.0 in Q4 2019.

• Dividends payables for Q4 2019 came in at $600000.0, down 48.91% year-over-year; the trailing twelve-month figure through Dec 2019 was $600000.0 (down 48.91% YoY), and the FY2019 annual result was $600000.0, down 48.91% from the prior year.
• Dividends payables held at $600000.0 in Q4 2019 per MTNB's latest filing, from $600000.0 in the prior quarter.
• Over five years, Dividends payables peaked at $1.2 million in Q3 2018 and troughed at $600.0 in Q1 2018.
• A 3-year average of $812218.0 and a median of $887143.0 in 2017 frame the typical range for Dividends payables.
• On a YoY basis, Dividends payables climbed as much as 195614.33% in 2019 and fell as far as 48.91% in 2019.
• A 3-year view of Dividends payables shows it stood at $600000.0 in 2017, then soared by 95.71% to $1.2 million in 2018, then plunged by 48.91% to $600000.0 in 2019.
• Business Quant data shows MTNB's Dividends payables at $600000.0 in Q4 2019, $600000.0 in Q3 2019, and $1.2 million in Q2 2019.